关注
Karen Abboud
Karen Abboud
Pharmacy Clinical Specialist, Houston Methodist Hospital
在 houstonmethodist.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Targeting the androgen receptor signaling pathway in advanced prostate cancer
C Chung, K Abboud
American Journal of Health-System Pharmacy 79 (15), 1224-1235, 2022
102022
Pancreatic tumorigenesis: Precursors, genetic risk factors and screening
M Badheeb, A Abdelrahim, A Esmail, G Umoru, K Abboud, E Al-Najjar, ...
Current Oncology 29 (11), 8693-8719, 2022
82022
Immune checkpoint inhibitors for solid tumors in the adjuvant setting: current progress, future directions, and role in transplant oncology
K Abboud, G Umoru, A Esmail, A Abudayyeh, N Murakami, HO Al-Shamsi, ...
Cancers 15 (5), 1433, 2023
62023
Antibiotic irrigation solutions for prevention of surgical site infections: A call to action
K Abboud, J Blee, PJ Shah
American Journal of Health-System Pharmacy 77 (24), 2040-2041, 2020
62020
Sequencing and combination of current small‐molecule inhibitors for chronic lymphocytic leukemia: Where is the evidence?
C Chung, G Umoru, K Abboud, E Hobaugh
European Journal of Haematology 111 (1), 15-28, 2023
32023
Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics
K Abboud, G Umoru, B Trachtenberg, V Ajewole
Cardio-Oncology 10 (1), 22, 2024
2024
Outcomes with Second-line Treatment Following First Line Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma
A Abudayyeh, A Esmail, A Kaseb, J Xu, K Abboud, G Umoru, ...
HPB 25, S321, 2023
2023
Utilization of Atezolizumab Plus Bevacizumab as Subsequent-line Therapy in Patients with Unresectable Hepatocellular Carcinoma
A Abudayyeh, A Esmail, A Kaseb, J Xu, G Umoru, K Abboud, ...
HPB 25, S321-S322, 2023
2023
系统目前无法执行此操作，请稍后再试。
文章 1–8
共建清朗的网络空间,如遇有害信息,请举报。
本站数据皆整合自互联网公开资源索引,方便科研学术方面查询,并不存储相关数据资源;如对此有异议,请联系我们解决.
© 2023 学术资源搜索   @联系我们 | 申请短期会员 | 数据源提交